MARC record from Internet Archive

LEADER: 11476cam 22008654a 4500
001 ocm60414556
003 OCoLC
005 20220602020415.0
008 050516s2005 nyua b 101 0 eng
010 $a 2005014243
040 $aDNLM/DLC$beng$cDLC$dNLM$dBAKER$dC#P$dIXA$dCOU$dBTCTA$dYDXCP$dLVB$dUQ1$dUBY$dGEBAY$dOCLCQ$dIG#$dOCLCO$dOCLCA$dOCLCQ$dOCLCO$dOCLCF$dOCL$dOCLCO$dOCLCQ$dOCLCO$dUKMGB$dOCLCO$dXFF$dOCLCO$dOCLCA$dOCLCQ$dOCLCA$dOCLCQ$dOCLCO$dNLE$dOCLCO$dOCLCA$dOCLCO
015 $aGBA600379$2bnb
016 $a101247991
016 7 $a101247991$2DNLM
016 7 $a013333988$2Uk
020 $a1573316121$q(cloth ;$qalk. paper)
020 $a9781573316125$q(cloth ;$qalk. paper)
020 $a157331613X$q(pbk. ;$qalk. paper)
020 $a9781573316132$q(pbk. ;$qalk. paper)
035 $a(OCoLC)60414556
042 $apcc
050 00 $aQ11$b.N5 vol. 1051$aRC600
060 00 $aW1$bAN626YL v.1051 2005
060 10 $aWD 305$bI603a 2005
082 00 $a500 s$a616.97/8$222
111 2 $aInternational Conference on Autoimmunity$n(4th :$d2004 :$cBudapest, Hungary)
245 10 $aAutoimmune diseases and treatment :$borgan-specific and systemic disorders /$cedited by Yehuda Shoenfeld and M. Eric Gershwin.
260 $aNew York, N.Y. :$bNew York Academy of Sciences,$c2005.
300 $axiv, 815 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aAnnals of the New York Academy of Sciences ;$vv. 1051
504 $aIncludes bibliographical references and index.
505 0 $aOrgan-specific autoimmune diseases. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Apoptosis in human skin: role in pathogenesis of various diseases and relevance for therapy. Cancer-associated myositis: clinical features and prognostic signs. Control of type 1 autoimmune diabetes by naturally occurring CD4CD25 regulatory T lymphocytes in neonatal NOD mice. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis. Oxidized low-density lipoprotein/[beta]₂-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus. Autoantibodies to human [alpha]6 integrin in patients with bullous pemphigoid. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-[beta]1a treatment and their use as markers of disease activity. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Rheumatic fever: How S. pyogenes-primed peripheral T cells trigger heart valve lesions. Avidity of anti-[beta]₂-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. E2F1⁻/⁻C57BL/6 mice overexpressing a human bcl-2 transgene in B cells develop a mild autimmune syndrome. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies. Primary biliary cirrhosis: solving the enigma. The stages of type 1A diabetes. Soluble CD40L in plasma of patients with primary biliary cirrhosis. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity? Analysis of the foxp3/scurfin gene in Crohn's disease -- Systematic autoimmune diseases. Juvenile systemic sclerosis: a follow-up study of eight patients. Antifodrin antibodies in Sjögren's syndrome: a review. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Investigation of arthritic joint destruction by a novel fibroblast-based model. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Mon-organic versus multi-organic involvement in primary antiphospholipid syndrome. OxLDL/[beta]2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Anti-HSP60 immunity is already associated with atherosclerosis early in life. Determinants of vessel targeting in vasculitis. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Accelerated atherosclerosis in patients with systemic autoimmune diseases. Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region. Clinical correlations of potential activity markers in systemic sclerosis. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Cellular and molecular mechanisms of regulation of autoantibody production in lupus. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Predictive markers for development of severe organ involvement in patients with systemic sclerosis. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. New facet of antiphospholipid antibodies -- Treatment. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates. Increased spontaneous apoptosis of CD4CD25⁺ T cells in patients with active rheumatoid arthritis is reduced by infliximab. Synergistic effect of avemar on proinflammatory cytokine production and ras-mediated cell activation. Fermented wheat germ extract (avemar) in the treatment of cancer and autoimmune diseases. Open-label 24-month study evaluating infliximab therapy in patients with psoriatic spondyloarthropathy. Cyclosporine: from renal transplantation to autoimmune diseases. Autoimmunity and anti-TNF-[alpha] agents. Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium. Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin. Treatment of pemphigus vulgaris with protein A immunoadsorption: case report of long-term history showing favorable outcome. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse. Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders. Removal of pathogenic autoantibodies by immunoadsorption. Chemokine receptors: attractive targets for drug discovery. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases. Anticytokine therapy, especially anti-interferon-[gamma], as a pathogenetic treatment in TH-1 autoimmune diseases. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4⁺CD25⁺ regulatory T cells. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis. Pathogenesis of rheumatoid arthritis: targeting cytokines. Anti-inflammatory and immune regulatory properties of 5-androsten-3[beta], 17[beta]-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?
530 $aAlso available via the World Wide Web.
540 $aCurrent copyright fee: GBP28.00$c35\0.$5Uk
650 0 $aAutoimmune diseases$vCongresses.
650 0 $aAutoimmunity.
650 12 $aAutoimmune Diseases$ximmunology
650 22 $aAutoimmune Diseases$xtherapy
650 22 $aAutoimmunity
650 6 $aMaladies auto-immunes$vCongrès.
650 6 $aAuto-immunité.
650 7 $aAutoimmune diseases.$2fast$0(OCoLC)fst00822663
650 7 $aAutoaggressionskrankheit$2gnd
650 17 $aMaladie auto-immune.$2rasuqam
650 7 $aTraitement médical.$2rasuqam
655 0 $aElectronic books.
655 2 $aCongress
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 7 $aConference papers and proceedings.$2lcgft
655 7 $aActes de congrès.$2rvmgf
700 1 $aShoenfeld, Yehuda,$d1948-
700 1 $aGershwin, M. Eric,$d1946-
776 08 $iOnline version:$aInternational Conference on Autoimmunity (4th : 2004 : Budapest, Hungary).$tAutoimmune diseases and treatment.$dNew York, N.Y. : New York Academy of Sciences, 2005$w(OCoLC)988948340
830 0 $aAnnals of the New York Academy of Sciences ;$vv. 1051.
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/ecip0512/2005014243.html
856 41 $uhttp://www.annalsnyas.org/content/vol1051/issue1/$zConnect to full text and free abstracts online.
856 4 $31850-9999$uhttp://onlinelibrary.wiley.com/$xBLDSS
856 4 $uhttp://www.blackwell-synergy.com/toc/nyas/1051/1
938 $aBaker & Taylor$bBKTY$c145.00$d149.95$i1573316121$n0006465005$sactive
938 $aBaker & Taylor$bBKTY$c144.95$d144.95$i157331613X$n0006465007$sactive
938 $aBaker and Taylor$bBTCP$n2005014243
938 $aIngram$bINGR$n9781573316125
938 $aYBP Library Services$bYANK$n2406151
029 1 $aAU@$b000027183104
029 1 $aGEBAY$b9314873
029 1 $aNLGGC$b277102448
029 1 $aNLM$b101247991
029 1 $aNZ1$b9496572
029 1 $aUKMGB$b013333988
029 1 $aYDXCP$b2406151
994 $aZ0$bP4A
948 $hHELD BY P4A - 170 OTHER HOLDINGS